Continuous glucose monitors can dramatically improve blood sugar control among people with type 2 diabetes who aren’t yet ...

If you look at the tubeless market, you know, we're seeing growth rates in excess of 25% annually,” Tandem Diabetes CEO John Sheridan explains to Bloomberg Intelligence about the growth opportunities ...

A once-a-day habit many Americans have followed for years may soon shrink to a single shot a week.

Research reveals a link between osteocalcin and insulin resistance in obese children, suggesting early metabolic changes ...

GLP-1s can help manage blood sugar by stimulating insulin release, reducing glucose release from the liver, and slowing ...

A major clinical trial involving nearly 2,750 people with type 2 diabetes has revealed surprising results for a new daily ...

Researchers at Weill Cornell Medicine have identified a molecular pathway that contributes to the death of insulin-producing beta cells in the pancreas. Experiments with preclinical models and human ...

Never used an insulin pump? Neither had most people in the twiist trial. Here’s what the FDA clearance means for adults with ...

The European Commission approved Germany’s financial support after assessing the risks of Sanofi stopping insulin API ...

With Twiist already available in Type 1 diabetes, Sequel has made the automated insulin delivery system available for the ...

A protein called Miro1, found at elevated levels in the skeletal muscle of people with type 2 diabetes, may contribute to ...

Novo released new evidence that its experimental CagriSema injection can improve upon the weight loss with its blockbuster ...